Breast-conserving surgery : Analysis of reduction mammoplasty

Abstract

-BACKGROUND: Aiming to achieve better cosmetic results, techniques coming from aesthetic surgery have been applied to cancer treatment, giving birth to the so called "oncoplastic breast-conserving surgery". Reduction mammoplasty (called therapeutic mammoplasty when is used to treat cancer) is one of this techniques. -OBJECTIVE: Evaluating the outcomes obtained in patients with breast cancer treated with therapeutic mammoplasty at the Breast Unit of the Hospital Universitario Marqués de Valdecilla (HUMV, Santander, Spain) between 2005 and 2016. We were especially interested in the rates of positive surgical margins, complications and local recurrences. We wanted to know if complications had delayed the start of adjuvant treatment. -PATIENTS AND METHODS: We performed an observational study in a group of 68 patients undergoing therapeutic mammoplasty in HUMV between 2005 and 2016. Data of all patients were collected prospectively. We compiled data referring the characteristics of the patients and the tumor, the surgery, the adjuvant treatment and the long-term outcomes (follow-up). We performed data statistical analysis. -RESULTS: Mean age of the patients was 57 years (SD: 8). Median follow-up was 56 months. Positive margins rate was 16,18 %. 11 patients (16,18 %) had early complications. The number of local recurrences to date was 0 (0%). We didn't found differences in the delay of adjuvant treatment between complicated and non-complicated patients. -CONCLUSIONS: The outcomes of reduction mammoplasty in HUMV are similar to those published in scientific papers to date, with good results referring surgical margins, recurrences and complications. Complications didn't delay the start of adjuvant therapies in our series.